Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gamida Cell Ltd. - Ordinary Shares (NQ:GMDA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gamida Cell Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Analyst Ratings for Gamida Cell ↗
 
Via Benzinga
News headline image
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
News headline image
Gamida Cell's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Gamida Cell to Report Second Quarter 2023 Financial Results
From Gamida Cell Ltd.
Via Business Wire
News headline image
Expert Ratings for Gamida Cell ↗
 
Via Benzinga
News headline image
Analyst Expectations for Gamida Cell's Future ↗
 
Via Benzinga
News headline image
Earnings Outlook For Gamida Cell ↗
 
Via Benzinga
News headline image
Despite Early Approval Of Omidubicel, Analyst Says Longer-Term Financial Overhang Remains For Gamida Cell ↗
 
Via Benzinga
News headline image
Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv)
From Gamida Cell Ltd.
Via Business Wire
News headline image
Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
From Gamida Cell Ltd.
Via Business Wire
News headline image
Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
News headline image
Where Gamida Cell Stands With Analysts ↗
 
Via Benzinga
News headline image
Gamida Cell Appoints Terry Coelho as CFO
From Gamida Cell Ltd.
Via Business Wire
News headline image
Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
News headline image
Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
From Gamida Cell Ltd.
Via Business Wire
News headline image
Why MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off the day with an overview of all the biggest pre-market stock movers worth watching on Thursday morning! 
Via InvestorPlace
News headline image
Virax Biolabs (VRAX) Stock Soars on PCR Test DIstribution Agreement ↗
Virax Biolabs (VRAX) stock is on the rise Wednesday after the company secured a Marburg Virus Real Time PCR Kit distribution deal. 
Via InvestorPlace
News headline image
LUNR Stock Alert: The $719 Million Reason Intuitive Machines Is Rising Today ↗
Intuitive Machines (LUNR) stock is heading higher on Wednesday thanks to news of a $719 million, five-year award from NASA. 
Via InvestorPlace
News headline image
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
Via Benzinga
News headline image
Why Is Gamida Cell (GMDA) Stock Down 19% Today? ↗
Gamida Cell (GMDA) stock is falling on Wednesday after the cell therapy company revealed details of a public securities offering. 
Via InvestorPlace
News headline image
Gamida Cell Announces Pricing of $23 Million Public Offering of Securities
From Gamida Cell Ltd.
Via Business Wire
News headline image
Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket ↗
Gainers Clearmind Medicine Inc. (NASDAQ: CMND) jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for another dive into the biggest pre-market stock movers traders will want to know about on Wednesday morning! 
Via InvestorPlace
News headline image
Gamida Cell Announces Launch of Public Offering of Securities
From Gamida Cell Ltd.
Via Business Wire
News headline image
Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones turning higher on Tuesday. The Dow traded up 0.04% to 34,000.96 while the NASDAQ fell 0.13% to 12,141.79. The S&P 500, also rose,... 
Via Benzinga
News headline image
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... 
Via Benzinga
News headline image
Gamida Cell Stock Jumps Over 100% on FDA Approval
Gamida Cell Ltd. (NASDAQ: GMDA) is an Israeli-based developmental biotechnology company specializing in discovering and advancing cell therapies to fight bloo 
Via MarketBeat
News headline image
Gamida Cell (NASDAQ: GMDA) Announces its Omisirge Allogeneic Cell Therapy Receives FDA Approval
Gamida Cell Ltd. (NASDAQ: GMDA) is a biopharma company that is focused on utilizing cell therapy to create innovative therapeutics. 
Via Spotlight Growth
News headline image
Enovix (ENVX) Stock On The Move After Announcing $150 Million Offering ↗
Enovix (ENVX) stock is on the move Tuesday after the battery company announced the details of a $150 million private placement. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.